• Inhalation CDMO Vectura Expands HPAPI Capabilities contractpharma
    December 15, 2020
    Vectura Group, an inhalation contract and development manufacturing organization (CDMO), has expanded its capabilities to handle and develop highly potent active pharmaceutical ingredients (HPAPIs) at its facility in Chippenham, UK.
  • EQT makes $2.8 bn bid for Recipharm expresspharma
    December 15, 2020
    EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm’s closing price.
  • Ascentage Selects PharmaBlock as Preferred Provider contractpharma
    December 14, 2020
    PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.
  • atbtherapeutics Enters Manufacturing Agreement with iBio CDMO contractpharma
    December 10, 2020
    ​atbtherapeutics, a biopharmaceutical company building an oncology pipeline using its antibody–toxin-bioengineered “atbody,” has entered a long-term manufacturing agreement with iBio CDMO, a global leader in plant-based biologics manufacturing located ...
  • iBio to Provide CDMO Services for ATB Therapeutics contractpharma
    December 04, 2020
    iBio will produce ATB’s bioengineered antibody-toxin fusion proteins.
  • Sterling Makes Strategic Investment in ADC Bio contractpharma
    December 03, 2020
    Sterling Pharma Solutions, a global CDMO, has entered a new strategic partnership with ADC Biotechnology, a UK company specializing in antibody drug conjugates.
  • CDMO Stelis Continues Expansion contractpharma
    December 02, 2020
    ​Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...
  • AGC Biologics to Expand Biopharmaceutical CDMO Capacity prnasia
    December 01, 2020
    AGC Biologics announced that it will increase the production capacity of its Copenhagen facility. AGC Biologics will construct a new building on land adjacent to its current Copenhagen site, adding production floors with 2000L single-use bioreactors ...
  • August Bioservices Expands Operations in Nashville contractpharma
    November 23, 2020
    ​Tennessee governor Bill Lee, Department of Economic and Community Development commissioner Bob Rolfe, and August Bioservices LLC officials have announced that the August Bioservices will significantly expand its operations in Nashville.
  • Asahi Kasei Pharma Contracts ProBioGen contractpharma
    November 20, 2020
    ​ProBioGen AG has closed a master service agreement with Asahi Kasei Pharma. As a CDMO in high-tier cell line development till large scale GMP manufacturing, ProBioGen will use its proprietary technologies, like the CHO.
PharmaSources Customer Service